VVOS Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range

03

Price $0.15

Market Cap (MRQ) $2M

P/E (TTM) -0.1

EPS (TTM) $-1.90

Revenue (TTM) $21M

ROE (TTM) -6629.2%

Debt/Equity (MRQ) -4.1

52W Range $0–$3

VVOS Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view

04

range

bars

Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.

Stock splits 1

Ex-date	Split	Type
Oct. 27, 2023	1-for-25	Reverse

10-Year Performance Revenue, net income, margins and EPS trends

06

Revenue$17M

2019-12-31 → 2025-12-31

EPS$-2.07

2022-12-31 → 2025-12-31

Free Cash Flow$-18M

2020-12-31 → 2025-12-31

Net margin-121.8%

2020-12-31 → 2025-12-31

Valuation & Ratios 07–12

Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?

Metric	VVOS	5Y avg	Peer Median	Verdict
P/E (TTM)	-0.15Y avg ≈-1.1	≈-1.1	·	·
P/S (TTM)	0.15Y avg ≈19.1	≈19.1	·	·
P/B (MRQ)	-0.65Y avg ≈29.0	≈29.0	·	·
EV / EBITDA	-0.9	·	·	·
Price / FCF (TTM)	-0.15Y avg ≈-17.5	≈-17.5	·	·
Price / Cash Flow (TTM)	-0.15Y avg ≈-19.8	≈-19.8	·	·
EV / Revenue	0.9	·	·	·
EV / FCF	-0.9	·	·	·
Price / Tangible Book (MRQ)	-0.35Y avg ≈67.6	≈67.6	·	·

Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.

Profitability Gross, operating and net margins; ROE, ROA, ROIC

Metric	VVOS	5Y avg	Peer Median	Verdict
Gross Margin (TTM)	61.9%5Y avg ≈63.5%	≈63.5%	·	·
Operating Margin (TTM)	-107.9%5Y avg ≈-118.1%	≈-118.1%	·	·
EBITDA Margin	-106.5%5Y avg ≈-114.1%	≈-114.1%	·	·
Pretax Margin (TTM)	-122.6%5Y avg ≈-112.6%	≈-112.6%	·	·
Net Profit Margin (TTM)	-121.8%5Y avg ≈-112.6%	≈-112.6%	·	·
ROA (TTM)	-101.5%5Y avg ≈-94.2%	≈-94.2%	·	·
ROE (TTM)	-6629.2%5Y avg ≈-1570.3%	≈-1570.3%	·	·

Financial Health Debt, liquidity, solvency — balance sheet strength

Metric	VVOS	5Y avg	Peer Median	Verdict
Debt / Equity (MRQ)	-4.1	·	·	·
Current Ratio (MRQ)	0.25Y avg ≈1.3	≈1.3	·	·
Quick Ratio	0.25Y avg ≈1.1	≈1.1	·	·
Long-Term Debt / Equity (MRQ)	-0.1	·	·	·
Interest Coverage	-14.2	·	·	·

Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR

Metric	VVOS	5Y avg	Peer Median	Verdict
Revenue YoY	16.1%5Y avg ≈7.0%	≈7.0%	·	·
Revenue CAGR 3Y	2.9%5Y avg ≈0.30%	≈0.30%	·	·
Revenue CAGR 5Y	5.9%	·	·	·

Per Share Metrics EPS, book value per share, cash flow per share, dividend per share

Metric	VVOS	5Y avg	Peer Median	Verdict
EPS (Diluted)	$-2.075Y avg ≈$-10.33	≈$-10.33	·	·
Revenue / Share	$1.705Y avg ≈$5.34	≈$5.34	·	·
Cash Flow / Share	$-1.495Y avg ≈$-4.60	≈$-4.60	·	·
Cash / Share	$0.225Y avg ≈$0.67	≈$0.67	·	·

Capital Efficiency Asset turnover, inventory turnover, receivables turnover

Metric	VVOS	5Y avg	Peer Median	Verdict
Asset Turnover	0.95Y avg ≈0.9	≈0.9	·	·
Receivables Turnover	17.35Y avg ≈27.8	≈27.8	·	·
Revenue / Employee	≈$65.1K	·	·	·

value · ≈ 5Y avg · industry median · verdict relative to median

Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date

14

Avg Surprise -3.2%

Period	Report	EPS Actual	EPS Est	Surprise
June 30, 2026	Aug 14, 2026	$-0.31	$-0.39	21.4%
March 31, 2026	May 20, 2026	$-0.52	$-0.46	-12.5%
Dec. 31, 2025		$-0.58	$-0.49	-17.6%
Sept. 30, 2025		$-0.49	$-0.52	5.8%
June 30, 2025		$-0.55	$-0.39	-40.1%
March 31, 2025		$-0.45	$-0.41	-10.3%
Dec. 31, 2024		$-0.28	$-0.40	30.5%

Full Fundamentals All metrics by year — income statement, balance sheet, cash flow

15

Income Statement 17

Metric	2025	2024	2023	2022	2021	2020	2019
Revenue	$17M	$15M	$14M	$16M	$17M	$13M	$11M
Cost of Revenue	$7M	$6M	$6M	$200.0K	$400.0K	$100.0K	·
Gross Profit	$11M	$9M	$8M	$10M	$13M	$10M	$9M
R&D Expense	$100.0K	$100.0K	$100.0K	$200.0K	$200.0K	·	·
SG&A Expense	$28M	$18M	$22M	$29M	$26M	$16M	$16M
Operating Expenses	$30M	$20M	$26M	$35M	$33M	$22M	$19M
Operating Income	$-20M	$-11M	$-17M	$-25M	$-20M	$-12M	$-11M
Interest Expense	$1M	·	·	·	$14.0K	$96.0K	$137.9K
Interest Income	·	·	·	·	$117.0K	$79.0K	$21.1K
Other Non-op	$-1M	$-110.0K	$-212.0K	$-190.0K	$-9.0K	·	·
Pretax Income	$-21M	$-11M	$-14M	$-24M	$-20M	$-12M	$-11M
Net Income	$-21M	$-11M	$-14M	$-24M	$-20M	$-12M	$-11M
EPS (Basic)	$-2.07	$-2.22	$-11.14	$-25.90	$-0.96	·	·
EPS (Diluted)	$-2.07	$-2.22	$-11.14	$-25.90	·	·	·
Shares (Basic)	10,273,881	5,019,886	1,219,381	920,592	21,233,485,000	·	·
Shares (Diluted)	10,273,881	5,019,886	1,219,381	920,592	·	·	·
EBITDA	$-19M	$-11M	$-17M	$-24M	$-20M	$-12M	·

Balance Sheet 25

Metric	2025	2024	2023	2022	2021	2020	2019
Cash & Equivalents	$2M	$6M	$2M	$4M	$24M	$18M	$469.4K
Receivables	$2M	$430.0K	$202.0K	$457.0K	$1M	$1M	$871.3K
Prepaid Expense	$774.0K	$783.0K	$616.0K	$1M	$2M	$673.0K	$295.0K
Current Assets	$4M	$7M	$2M	$5M	$27M	$20M	$2M
PP&E (Net)	$4M	$3M	$3M	$3M	$3M	$872.0K	$1M
PP&E (Gross)	$7M	$6M	$6M	$5M	$4M	$2M	$2M
Accum. Depreciation	$3M	$3M	$2M	$2M	$1M	$801.0K	$502.5K
Goodwill	$9M	$3M	$3M	$3M	$3M	$3M	$3M
Intangibles	$4M	$409.0K	$420.0K	$302.0K	$341.0K	$270.0K	$689.2K
Total Assets	$25M	$15M	$11M	$14M	$34M	$25M	$8M
Accounts Payable	$2M	$1M	$2M	$1M	$920.0K	$781.0K	$1M
Accrued Liabilities	$6M	$2M	$2M	$2M	$3M	$2M	$1M
Short-term Debt	$8M	·	·	·	·	·	·
Current Liabilities	$18M	$5M	$7M	$7M	$8M	$8M	$9M
Capital Leases	$4M	$1M	$2M	$2M	·	·	·
Other Non-current Liabilities	$1M	·	·	·	·	·	·
Total Liabilities	$27M	$7M	$10M	$9M	$8M	$8M	$9M
Long-term Debt	$727.0K	·	·	·	$1M	$1M	$4M
Total Debt	$17M	·	·	·	$1M	$1M	·
Common Stock	$1.0K	·	·	·	$2.0K	$2.0K	$1.2K
Paid-in Capital	$124M	$112M	$93M	$84M	$81M	$52M	$20M
Retained Earnings	$-125M	$-104M	$-93M	$-79M	$-56M	$-35M	$-23M
Stockholders' Equity	$-1M	$8M	$411.0K	$5M	$26M	$17M	$-3M
Liabilities + Equity	$25M	$15M	$11M	$14M	$34M	$25M	$8M
Shares Outstanding	9,286,609	5,889,520	1,833,877	920,592	23,012,119	18,209,452	12,444,165

Cash Flow 14

Metric	2025	2024	2023	2022	2021	2020	2019
D&A	$1M	$581.0K	$621.0K	$669.0K	$733.0K	$718.0K	$751.2K
Stock-based Comp	$661.0K	$762.0K	$1M	$2M	$3M	$2M	$2M
Amort. of Intangibles	$600.0K	$100.0K	$100.0K	$100.0K	$300.0K	$400.0K	$424.4K
Other Non-cash	$4M	$-3M	$-90.0K	$1M	·	·	·
Operating Cash Flow	$-15M	$-13M	$-12M	$-20M	$-16M	$-6M	$-5M
CapEx	$2M	$568.0K	$803.0K	$924.0K	$2M	$120.0K	$175.6K
Investing Cash Flow	$-8M	$-568.0K	$-853.0K	$-924.0K	$-3M	$-120.0K	$86.2K
Debt Issued	$11M	·	·	·	·	·	·
Net Debt Issued	$11M	·	·	·	$-25.0K	$-75.0K	·
Stock Issued	$6M	$8M	$4M	·	$28M	$22M	$1M
Net Stock Activity	$6M	$8M	·	·	$28M	$22M	·
Financing Cash Flow	$19M	$18M	$11M	·	$24M	$24M	$4M
Net Change in Cash	$-4M	$5M	$-2M	$-21M	$6M	$18M	$-785.4K
Free Cash Flow	$-18M	$-13M	$-13M	$-21M	$-18M	$-6M	·

Profitability 7

Metric	2025	2024	2023	2022	2021	2020	2019
Gross Margin	60.4%	60.0%	59.9%	62.5%	74.7%	79.7%	·
Operating Margin	-114.1%	-74.3%	-125.3%	-156.2%	-120.7%	-92.1%	·
Net Margin	-121.4%	-74.1%	-98.4%	-148.8%	-120.2%	-92.3%	·
Pretax Margin	-121.7%	-74.1%	-98.4%	-148.8%	-120.2%	-92.3%	·
EBITDA Margin	-106.5%	-70.5%	-120.8%	-152.0%	-120.7%	-92.1%	·
ROA	-104.7%	-85.6%	-111.1%	-100.6%	-68.8%	-73.3%	·
ROE	-1368.9%	-142.6%	-5944.4%	-325.4%	-70.0%	-160.8%	·

Liquidity & Solvency 5

Metric	2025	2024	2023	2022	2021	2020	2019
Current Ratio	0.2	1.5	0.3	0.8	3.6	2.6	·
Quick Ratio	0.2	1.3	0.3	0.6	3.4	2.5	·
Debt / Equity	-11.4	·	·	·	0.0	0.1	·
LT Debt / Equity	-0.3	·	·	·	·	0.0	·
Interest Coverage	-14.2	·	·	·	-1455.9	-124.5	·

Efficiency 2

Metric	Trend	2025	2024	2023	2022	2021	2020	2019
Asset Turnover		0.9	1.2	1.1	0.7	0.6	0.8	·
Receivables Turnover		17.3	47.6	41.9	19.3	12.8	11.4	·

Per Share 5

Metric	2025	2024	2023	2022	2021	2020	2019
Book Value / Share	$-0.16	$1.35	$0.22	$0.21	$1.11	$0.93	·
Revenue / Share	$1.70	$2.99	$11.32	·	·	·	·
Cash Flow / Share	$-1.49	$-2.53	$-9.80	·	·	·	·
Cash / Share	$0.22	$1.06	$0.90	$0.15	$1.04	$1.00	·
EPS (TTM)	$-2.07	$-2.22	$-11.14	$-25.90	·	·	·

Growth Rates 3

Metric	2025	2024	2023	2022	2021	2020	2019
Revenue YoY	16.1%	8.9%	-13.9%	-5.1%	29.2%	·	·
Revenue CAGR 3Y	2.9%	-3.8%	1.8%	·	·	·	·
Revenue CAGR 5Y	5.9%	·	·	·	·	·	·

Valuation (TTM) 14

Metric	2025	2024	2023	2022	2021	2020	2019
Revenue TTM	$17M	$15M	$14M	$16M	$17M	$13M	·
Net Income TTM	$-21M	$-11M	$-14M	$-24M	$-20M	$-12M	·
Market Cap	$19M	$25M	$23M	$231M	$1.29B	$2.69B	·
Enterprise Value	$34M	·	·	·	$1.27B	$2.67B	·
P/E	-1.0	-1.9	-1.1	-0.4	·	·	·
P/S	1.1	1.7	1.7	14.4	76.7	205.9	·
P/B	-12.7	3.2	55.5	48.2	50.7	159.0	·
P / Tangible Book	·	5.4	·	139.7	57.9	192.5	·
P / Cash Flow	-1.2	-2.0	-1.9	-11.8	-82.3	-473.6	·
P / FCF	-1.1	-1.9	-1.8	-11.3	-71.4	-463.8	·
EV / EBITDA	-1.8	·	·	·	-62.4	-222.1	·
EV / FCF	-1.9	·	·	·	-70.1	-460.9	·
EV / Revenue	1.9	·	·	·	75.3	204.6	·
Earnings Yield	-102.0%	-51.7%	-89.5%	-257.7%	·	·	·

Income Statement 16

Metric	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Revenue	$5M	$5M	$4M	$7M	$4M	$3M	$4M	$4M	$4M	$3M	$3M	$3M	$3M	$4M	$4M	$4M
Cost of Revenue	·	·	·	·	·	·	·	·	·	$100.0K	$5M	$100.0K	$100.0K	$100.0K	$-100.0K	$100.0K
Gross Profit	$3M	$3M	$3M	$4M	$2M	$2M	$2M	$2M	$3M	$2M	$2M	$2M	$2M	$2M	$2M	$2M
R&D Expense	·	·	·	·	·	·	·	·	·	$100.0K	$-200.0K	$100.0K	$100.0K	$100.0K	$-100.0K	$100.0K
SG&A Expense	$7M	$9M	$9M	$8M	$6M	$5M	$4M	$4M	$4M	$5M	$5M	$5M	$6M	$7M	$6M	$7M
Operating Expenses	$8M	$10M	$9M	$9M	$7M	$5M	$5M	$5M	$5M	$6M	$6M	$5M	$7M	$7M	$8M	$8M
Operating Income	$-5M	$-7M	$-6M	$-5M	$-5M	$-4M	$-3M	$-3M	$-2M	$-4M	$-4M	$-4M	$-5M	$-5M	$-6M	$-5M
Interest Expense	$1M	$1M	$800.0K	$500.0K	·	·	·	·	·	·	·	·	·	·	·	·
Other Non-op	$-1M	$-1M	$-635.0K	$-679.0K	$-163.0K	$-4.0K	$-69.0K	$-18.0K	$-22.0K	$-1.0K	$15.0K	$-53.0K	$-225.0K	$51.0K	$-79.0K	$-36.0K
Pretax Income	$-6M	$-8M	$-7M	$-5M	$-5M	$-4M	$-3M	$-3M	$-2M	$-4M	$-4M	$-2M	$-6M	$-2M	$-6M	$-5M
Net Income	$-5M	$-8M	$-7M	$-5M	$-5M	$-4M	$-3M	$-3M	$-2M	$-4M	$-4M	$-2M	$-6M	$-2M	$-6M	$-5M
EPS (Basic)	$-0.31	$-0.52	$-0.58	$-0.49	$-0.55	$-0.45	$0.41	$-0.40	$-0.60	$-1.63	$-3.05	$-1.75	$-4.62	$-1.72	$-18.92	$-6.40
EPS (Diluted)	$-0.31	$-0.52	$-0.58	$-0.49	$-0.55	$-0.45	$0.41	$-0.40	$-0.60	$-1.63	$-3.05	$-1.75	$-4.62	$-1.72	$-18.92	$-6.40
Shares (Basic)	17,681,945	14,634,115	·	10,963,590	9,087,202	8,595,288	·	6,615,320	3,228,363	2,308,154	·	1,197,258	1,197,258	990,669	·	849,446
Shares (Diluted)	17,681,945	14,634,115	·	10,963,590	9,087,202	8,595,288	·	6,615,320	3,228,363	2,308,154	·	1,197,258	1,197,258	990,669	·	849,446
EBITDA	$-5M	$-7M	·	$-5M	$-5M	$-4M	·	$-3M	$-2M	$-4M	·	$-3M	$-5M	$-5M	·	$-5M

Balance Sheet 25

Metric	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Cash & Equivalents	$2M	$2M	$2M	$3M	$4M	$2M	$6M	$6M	$7M	$3M	$2M	$988.0K	$4M	$7M	$4M	$7M
Receivables	$1M	$2M	$2M	$2M	$2M	$718.0K	$430.0K	$454.0K	$395.0K	$525.0K	$202.0K	$228.0K	$327.0K	$321.0K	$457.0K	$866.0K
Prepaid Expense	$1M	$940.0K	$774.0K	$565.0K	$695.0K	$547.0K	$783.0K	$634.0K	$554.0K	$475.0K	$616.0K	$769.0K	$1M	$1M	$1M	$2M
Current Assets	$4M	$5M	$4M	$6M	$7M	$4M	$7M	$7M	$8M	$4M	$2M	$2M	$5M	$9M	$5M	$10M
PP&E (Net)	$4M	$4M	$4M	$6M	$5M	$3M	$3M	$3M	$3M	$3M	$3M	$3M	$3M	$3M	$3M	$3M
PP&E (Gross)	$7M	$7M	$7M	$9M	$8M	$6M	$6M	$6M	$6M	$6M	$6M	$5M	$5M	$5M	$5M	$5M
Accum. Depreciation	$3M	$3M	$3M	$3M	$3M	$2M	$3M	$3M	$3M	$2M	$2M	$2M	$2M	$2M	$2M	$2M
Goodwill	$9M	$9M	$9M	$8M	$8M	$3M	$3M	$3M	$3M	$3M	$3M	$3M	$3M	$3M	$3M	$3M
Intangibles	$4M	$4M	$4M	$2M	$2M	$358.0K	$409.0K	$383.0K	$395.0K	$408.0K	$420.0K	$433.0K	$445.0K	$458.0K	$302.0K	$312.0K
Total Assets	$24M	$25M	$25M	$26M	$26M	$11M	$15M	$15M	$16M	$12M	$11M	$10M	$14M	$17M	$14M	$18M
Accounts Payable	$3M	$2M	$2M	$2M	$2M	$1M	$1M	$1M	$2M	$2M	$2M	$2M	$1M	$1M	$1M	$644.0K
Accrued Liabilities	$7M	$6M	$6M	$3M	$2M	$2M	$2M	$2M	$2M	$2M	$2M	$2M	$2M	$2M	$2M	$2M
Short-term Debt	$8M	$7M	$8M	$8M	$8M	·	·	·	·	·	·	·	·	·	·	·
Current Liabilities	$20M	$18M	$18M	$7M	$6M	$5M	$5M	$5M	$7M	$8M	$7M	$7M	$8M	$8M	$7M	$6M
Capital Leases	$3M	$4M	$4M	$3M	$3M	$932.0K	$1M	$1M	$1M	$1M	$2M	$2M	$2M	$2M	$2M	$2M
Other Non-current Liabilities	$950.0K	$1M	$1M	$1M	$1M	·	·	·	·	·	·	·	·	·	·	·
Total Liabilities	$28M	$26M	$27M	$23M	$21M	$7M	$7M	$8M	$9M	$11M	$10M	$10M	$12M	$10M	$9M	$9M
Long-term Debt	$582.0K	$617.0K	$753.0K	$9M	$8M	·	·	·	·	·	·	·	·	·	·	·
Total Debt	$16M	$15M	·	$17M	$15M	·	·	·	·	·	·	·	·	·	·	·
Common Stock	$1.0K	$1.0K	$1.0K	$1.0K	·	·	·	·	·	·	·	$3.0K	$3.0K	$3.0K	·	$2.0K
Paid-in Capital	$134M	$132M	$124M	$121M	$118M	$112M	$112M	$109M	$105M	$97M	$93M	$89M	$89M	$88M	$84M	$83M
Retained Earnings	$-139M	$-133M	$-125M	$-118M	$-113M	$-108M	$-104M	$-101M	$-99M	$-97M	$-93M	$-89M	$-87M	$-81M	$-79M	$-73M
Stockholders' Equity	$-4M	$-1M	$-1M	$3M	$5M	$4M	$8M	$8M	$6M	$582.0K	$411.0K	$46.0K	$2M	$7M	$5M	$10M
Liabilities + Equity	$24M	$25M	$25M	$26M	$26M	$11M	$15M	$15M	$16M	$12M	$11M	$10M	$14M	$17M	$14M	$18M
Shares Outstanding	14,531,617	13,486,006	9,286,609	8,266,877	7,324,807	5,889,520	5,889,520	4,765,300	3,401,488	2,731,270	1,833,877	1,197,258	29,928,786	29,928,786	920,592	23,012,119

Cash Flow 14

Metric	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
D&A	$510.0K	$454.0K	$442.0K	$384.0K	$306.0K	$177.0K	$144.0K	$146.0K	$145.0K	$146.0K	$149.0K	$149.0K	$148.0K	$175.0K	$169.0K	$176.0K
Stock-based Comp	$50.0K	$151.0K	$47.0K	$55.0K	$242.0K	$317.0K	$57.0K	$142.0K	$270.0K	$293.0K	$152.0K	$189.0K	$459.0K	$306.0K	$775.0K	$350.0K
Amort. of Intangibles	$200.0K	$200.0K	$300.0K	$100.0K	$100.0K	$100.0K	$-200.0K	$100.0K	$100.0K	$100.0K	$-200.0K	$100.0K	$100.0K	$100.0K	$-200.0K	$100.0K
Other Non-cash	·	·	·	·	·	$-426.0K	·	·	·	$808.0K	·	·	·	$-2M	·	·
Operating Cash Flow	$-3M	$-6M	$-4M	$-4M	$-3M	$-4M	$-3M	$-4M	$-3M	$-3M	$-3M	$-3M	$-3M	$-4M	$-3M	$-6M
CapEx	$416.0K	$18.0K	$2M	$-83.0K	$771.0K	$122.0K	$165.0K	$192.0K	$60.0K	$151.0K	$165.0K	$154.0K	$245.0K	$239.0K	$200.0K	$100.0K
Investing Cash Flow	$-416.0K	$-18.0K	$-2M	$83.0K	$-6M	$-122.0K	$-165.0K	$-192.0K	$-60.0K	$-151.0K	$-165.0K	$-154.0K	$-245.0K	$-289.0K	$-200.0K	$-100.0K
Debt Issued	$2M	$1M	$1M	$-417.0K	·	·	·	·	·	·	·	·	·	·	·	·
Net Debt Issued	·	$1M	·	·	·	·	·	·	·	·	·	·	·	·	·	·
Stock Issued	$291.0K	$342.0K	$3M	$2M	·	·	$4M	·	·	·	·	·	·	·	·	·
Net Stock Activity	·	$342.0K	·	·	·	·	·	·	·	·	·	·	·	·	·	·
Financing Cash Flow	$3M	$6M	$4M	$3M	·	·	$3M	$4M	$7M	$4M	$4M	$0	$0	$7M	·	·
Net Change in Cash	$-336.0K	$81.0K	$-1M	$-1M	$2M	$-4M	$-51.0K	$-592.0K	$4M	$968.0K	$655.0K	$-3M	$-3M	$4M	$-3M	$-6M
Free Cash Flow	·	$-6M	·	·	·	$-4M	·	·	·	$-3M	·	·	·	$-4M	·	·

Profitability 7

Metric	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Gross Margin	57.3%	59.5%	·	58.0%	55.2%	50.0%	·	60.5%	65.4%	56.6%	·	57.5%	61.8%	60.6%	·	58.8%
Operating Margin	-93.6%	-128.7%	·	-69.8%	-127.4%	-129.9%	·	-68.5%	-47.8%	-110.7%	·	-105.7%	-133.1%	-129.8%	·	-127.3%
Net Margin	-106.4%	-149.4%	·	-79.6%	-131.2%	-128.1%	·	-67.8%	-47.6%	-110.1%	·	-63.4%	-162.8%	-44.1%	·	-128.0%
Pretax Margin	-107.2%	-150.8%	·	-79.6%	-131.2%	-128.1%	·	-67.8%	-47.6%	-110.1%	·	·	·	·	·	-128.0%
EBITDA Margin	-93.6%	-128.7%	·	-69.8%	-127.4%	-124.0%	·	-68.5%	-47.8%	-106.4%	·	-105.7%	-133.1%	-125.2%	·	-127.3%
ROA	-21.9%	-42.3%	·	-26.4%	-23.9%	-33.5%	·	-20.4%	-13.0%	-26.0%	·	-14.6%	-29.0%	-7.3%	·	-18.3%
ROE	-1427.3%	-470.0%	·	-105.9%	-91.7%	-154.9%	·	-67.8%	-45.7%	-99.4%	·	-42.3%	-65.2%	-12.2%	·	-25.7%

Liquidity & Solvency 5

Metric	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Current Ratio	0.2	0.3	·	0.8	1.0	0.8	·	1.4	1.2	0.4	·	0.3	0.6	1.1	·	1.6
Quick Ratio	0.2	0.2	·	0.7	0.9	0.7	·	1.3	1.1	0.4	·	0.2	0.5	0.9	·	1.3
Debt / Equity	-4.1	-13.0	·	6.6	3.4	·	·	·	·	·	·	·	·	·	·	·
LT Debt / Equity	-0.1	-0.4	·	3.3	1.7	·	·	·	·	·	·	·	·	·	·	·
Interest Coverage	-4.4	-6.0	·	-9.5	·	·	·	·	·	·	·	·	·	·	·	·

Efficiency 2

Metric	Trend	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Asset Turnover		0.2	0.3	·	0.3	0.2	0.3	·	0.3	0.3	0.2	·	0.2	0.2	0.2	·	0.1
Receivables Turnover		3.4	4.1	·	5.2	3.8	4.9	·	11.3	11.2	8.1	·	6.0	6.1	5.8	·	1.8

Per Share 5

Metric	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Book Value / Share	$-0.26	$-0.08	·	$0.31	$0.63	$0.75	·	$1.61	$1.87	$0.21	·	$0.04	$0.07	$0.23	·	$0.43
Revenue / Share	$0.29	$0.35	·	$0.62	$0.42	$0.35	·	$0.58	$1.26	$1.48	·	$2.76	$0.11	·	·	·
Cash Flow / Share	·	$-0.41	·	·	·	$-0.44	·	·	·	$-1.09	·	·	·	·	·	·
Cash / Share	$0.12	$0.16	·	$0.37	$0.60	$0.40	·	$1.32	$2.03	$0.96	·	$0.83	$0.13	$0.24	·	$0.29
EPS (TTM)	$-1.90	$-2.14	·	$-1.08	$-0.99	$-1.04	·	$-5.68	$-7.03	$-11.05	·	$-27.01	$-31.66	$-27.37	·	·

Valuation (TTM) 11

Metric	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Revenue TTM	$21M	$20M	·	$17M	$14M	$15M	·	$15M	$14M	$13M	·	$15M	$15M	$16M	·	$16M
Net Income TTM	$-25M	$-25M	·	$-17M	$-14M	$-11M	·	$-13M	$-12M	$-16M	·	$-15M	$-19M	$-20M	·	$-25M
Market Cap	$7M	$16M	·	$26M	$23M	$17M	·	$12M	$8M	$13M	·	$6M	$382M	$255M	·	$374M
Enterprise Value	$21M	$29M	·	$39M	$34M	·	·	·	·	·	·	·	·	·	·	·
P/E	-0.2	-0.6	·	-2.9	-3.2	-2.7	·	-0.5	-0.3	-0.4	·	-0.2	-0.4	-0.3	·	·
P/S	0.3	0.8	·	1.5	1.6	1.1	·	0.9	0.5	1.0	·	0.4	24.7	15.7	·	22.7
P/B	-1.7	-14.0	·	10.1	5.1	3.8	·	1.6	1.2	22.7	·	124.9	181.2	36.5	·	37.9
P / Tangible Book	·	·	·	·	·	13.9	·	2.8	2.4	·	·	·	·	69.1	·	55.8
P / Cash Flow	·	-2.6	·	·	·	-4.4	·	·	·	-5.2	·	·	·	-72.1	·	·
EV / Revenue	1.0	1.5	·	2.3	2.4	·	·	·	·	·	·	·	·	·	·	·
Earnings Yield	-417.6%	-181.4%	·	-34.8%	-31.3%	-36.5%	·	-217.6%	-316.7%	-228.8%	·	-562.7%	-248.3%	-321.1%	·	·

Most recent period on the left · null values shown as ·

Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years

16

Metric	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Revenue	$17M	$15M	$14M	$16M	$17M
Gross Margin %	60.4%	60.0%	59.9%	62.5%	74.7%
Operating Margin %	-114.1%	-74.3%	-125.3%	-156.2%	-120.7%
Net Income	$-21M	$-11M	$-14M	$-24M	$-20M
Diluted EPS	$-2.07	$-2.22	$-11.14	$-25.90	·

Metric	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Debt / Equity	-11.4	·	·	·	0.0
Current Ratio	0.2	1.5	0.3	0.8	3.6
Quick Ratio	0.2	1.3	0.3	0.6	3.4

Metric	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Free Cash Flow	$-18M	$-13M	$-13M	$-21M	$-18M

Institutional owners (13F) 24 filers · $1.0M total · As of June 30, 2026

17

Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.

Holders 24

Value held $1.0M

New positions 2

Exited positions 4

Institutional activity — Q2 2026 vs prior quarter

New positions	Exited positions	Increased	Decreased	Net shares change
2 (-6 vs prior Q)	4 (+3 vs prior Q)	3 (0 vs prior Q)	4 (+2 vs prior Q)	-1.3M

Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.

Institution	Value	Shares	% of tracked 13F	Type
VANGUARD GROUP INC	$617,447	304,161	61.74%	Shares
Cutter & CO Brokerage, Inc.	$139,935	49,100	13.99%	Shares
GEODE CAPITAL MANAGEMENT, LLC	$38,632	85,001	3.86%	Shares
IHT Wealth Management, LLC	$34,877	76,736	3.49%	Shares
VANGUARD CAPITAL MANAGEMENT LLC	$27,586	60,629	2.76%	Shares
COMMONWEALTH EQUITY SERVICES, LLC	$19,320	42,500	1.93%	Shares
B. Riley Wealth Advisors, Inc.	$18,767	38,066	1.88%	Shares
UBS Group AG	$17,815	39,154	1.78%	Shares
Centurion Wealth Management LLC	$16,219	35,684	1.62%	Shares
BlackRock, Inc.	$12,643	27,817	1.26%	Shares
STATE STREET CORP	$11,327	24,922	1.13%	Shares
Sequoia Financial Advisors, LLC	$10,908	24,000	1.09%	Shares
VANGUARD FIDUCIARY TRUST CO	$10,662	23,432	1.07%	Shares
NORTHERN TRUST CORP	$9,442	20,775	0.94%	Shares
Acorn Wealth Advisors, LLC	$6,716	14,776	0.67%	Shares
SUSQUEHANNA INTERNATIONAL GROUP, LLP	$4,579	10,075	0.46%	Shares
Tower Research Capital LLC (TRC)	$2,368	5,211	0.24%	Shares
OSAIC HOLDINGS, INC.	$516	1,143	0.05%	Shares
SIGNATUREFD, LLC	$249	547	0.02%	Shares
Blue Trust, Inc.	$73	160	0.01%	Shares
Kozak & Associates, Inc.	$24	49	0.00%	Shares
Global Retirement Partners, LLC	$10	23	0.00%	Shares
MORGAN STANLEY	$3	7	0.00%	Shares
ROYAL BANK OF CANADA	$0	4	0.00%	Shares

Activists & 5%+ owners 1 position

18

Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.

Filer	Filed	Stake	Status	Purpose	Filing
V-CO Investors LLC, V-Co Investors 2 LLC, V-Co Investors 3 LLC, V-Co Investors 4 LLC, SP Manager LLC, Michael C. Skaff ×3 filings	July 15, 2026	19.90%	Initial filing	Passive investment	SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

Company insiders 10 insiders · 3 officers · 8 directors

19

Insider	Role	Last activity	Shares owned	Buys 12m	Net 12m
Ronald Kirk Huntsman	Chief Executive Officer	June 30, 2026 J	85,910	0	$0
Bradford K. Amman	Principal Accounting Officer	July 31, 2026 A	250,080	0	$0
Gurdev Dave Singh	Chief Medical Officer	Aug. 5, 2021 A	·	0	$0
Gregg C Johnson	Director	Sept. 14, 2026 A	·	0	$0
Leonard J Sokolow	Director	Sept. 14, 2026 A	·	0	$0
Ralph Elias Green	Director	June 20, 2024 A	·	0	$0
Mark F. Lindsay	Director	June 20, 2024 A	·	0	$0
Matthew Thompson	Director	June 20, 2024 A	·	0	$0
Anja B Krammer	Director	June 20, 2024 A	·	0	$0
Michael C. Skaff	10% owner	June 30, 2026 P	·	3	$3,189,222

Insiders from SEC Form 3/4/5 filings; net = open-market P/S only

ETF ownership Held by 1 ETF

20

Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.

Fund	Weight	Units	As of	Source
VXF · VANGUARD INDEX FUNDS	0.00%	60,629 SH	Aug. 19, 2026	Daily

VVOS Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside

21

rating · 9 analysts BUY

Median target $2.50 +1546.9%

2 22.2% Strong Buy

5 55.6% Buy

2 22.2% Hold

0 0.0% Sell

0 0.0% Strong Sell

12-Month Price Target

3 analysts · 2026-10-03

Mean target $2.12 +1294.4%

← Below all targets Current price $0.15

Low$0.75 Mean$2.12 High$3.10

Peer comparison (GICS sub-industry) Key metrics vs sector peers

22

FY basis, prices as of each company's last fiscal year-end close.

Ticker	Market Cap	P/E	Rev YoY	Net Margin	ROE	Gross Margin
VVOS	$19M	-1.0	16.1%	-121.4%	-1368.9%	60.4%
CVS	$100.87B	57.1	7.8%	0.44%	2.4%	·

My Metrics Your personal watchlist — selected rows from Full Fundamentals

26

Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.

Your selection is saved and follows you across all tickers.

VVOS Vivos Therapeutics, Inc. - Common Stock